Corcept Therapeutics to Announce First Quarter Financial Results and Corporate Update and Host Conference Call
April 30, 2015 16:05 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwired - Apr 30, 2015) - Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report first quarter financial results and provide a corporate update on May...
Warrant Exercises Generate $17.2 Million; Proceeds to Advance Next-Generation Compounds and Support Commercialization of Korlym(R)
April 01, 2015 16:05 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwired - Apr 1, 2015) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that...
Corcept Therapeutics Announces Nine Poster Presentations on Mifepristone for the Treatment of Cushing's Syndrome at the 97th Annual Endocrine Society Meeting
March 05, 2015 08:00 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwired - Mar 5, 2015) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the...
Corcept Therapeutics Announces 2014 Financial Results and Provides Clinical Update
March 04, 2015 16:05 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwired - Mar 4, 2015) - Corcept Therapeutics Incorporated (NASDAQ: CORT)
Q4 net loss narrowed to $0.04 per share, down from $0.11 per share in...
Corcept Therapeutics Announces Fourth Quarter and Full Year 2014 Revenue, Provides 2015 Revenue Guidance and Clinical Update
January 29, 2015 16:05 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwired - Jan 29, 2015) - Corcept Therapeutics Incorporated (NASDAQ: CORT)
Fourth quarter 2014 revenue grows to $9.0 million, a 24 percent...
Corcept Therapeutics to Announce Fourth Quarter and Full Year 2014 Revenue and Corporate Update and Host Conference Call
January 22, 2015 16:05 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwired - Jan 22, 2015) - Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report fourth quarter and full year 2014 revenue on January 29, 2015. The...
Corcept Therapeutics Announces Third Quarter 2014 Financial Results and Provides Corporate Update
November 04, 2014 16:05 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwired - Nov 4, 2014) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the...
Corcept Therapeutics to Announce Third Quarter Financial Results and Host Conference Call
October 28, 2014 16:05 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwired - Oct 28, 2014) - Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report third quarter financial results and provide a corporate update on...
Corcept Therapeutics Announces Second Quarter 2014 Financial Results and Provides Corporate Update
August 05, 2014 16:05 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwired - Aug 5, 2014) - Corcept Therapeutics Incorporated (NASDAQ: CORT)
Revenue increases 33 percent from prior quarter on continued uptake of...
Corcept Therapeutics to Announce Second Quarter Financial Results and Host Conference Call
July 29, 2014 16:05 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwired - Jul 29, 2014) - Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter financial results and provide a corporate update on...